Log In
Print
BCIQ
Print
Print this Print this
 

UFT

Also known as: Orzel, tegafur/uracil

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionCombination therapy of tegafur plus uracil
Molecular Target Thymidylate synthase
Mechanism of ActionThymidylate synthase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationColorectal cancer
Indication DetailsTreat first-line metastatic colorectal cancer (mCRC)
Regulatory Designation

Partner

Merck KGaA


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today